| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 18 | US 7 | 98.93 |
| Venous Thromboembolism Diagnosis and Management | Lifetime | 191 | US 78 | 99.40 |
| Central Venous Catheters and Hemodialysis | Lifetime | 94 | US 38 | 99.11 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 160 | US 58 | 98.66 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 493 | US 209 | 98.78 |
| Cardiac tumors and thrombi | Lifetime | 263 | US 140 | 97.43 |
| Platelet Disorders and Treatments | Lifetime | 457 | US 179 | 97.56 |
| Acute Myocardial Infarction Research | Lifetime | 736 | US 312 | 97.86 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 198 | US 111 | 95.87 |
| Hemophilia Treatment and Research | Lifetime | 211 | US 76 | 97.40 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 471 | US 183 | 92.06 |
| Intramuscular injections and effects | Lifetime | 585 | US 230 | 70.78 |
| Venous Thromboembolism Diagnosis and Management | 2021-2025 | 12 | US 5 | 99.69 |
| Blood Coagulation and Thrombosis Mechanisms | 2021-2025 | 4 | US 1 | 99.52 |
| Central Venous Catheters and Hemodialysis | 2021-2025 | 12 | US 2 | 98.42 |
| Platelet Disorders and Treatments | 2021-2025 | 34 | US 8 | 98.27 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 152 | US 41 | 98.70 |
| Hemophilia Treatment and Research | 2021-2025 | 17 | US 4 | 98.84 |
| Inflammatory Biomarkers in Disease Prognosis | 2021-2025 | 58 | US 3 | 94.47 |
| Heparin-Induced Thrombocytopenia and Thrombosis | 2021-2025 | 34 | US 6 | 94.95 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 176 | US 41 | 96.14 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | 2021-2025 | 88 | US 25 | 95.21 |
| Chemotherapy-induced cardiotoxicity and mitigation | 2021-2025 | 133 | US 50 | 91.47 |
| Blood groups and transfusion | 2021-2025 | 183 | US 63 | 91.81 |
| Lymphoma Diagnosis and Treatment | 2021-2025 | 745 | US 318 | 93.87 |
| Acute Myocardial Infarction Research | 2021-2025 | 739 | US 179 | 91.85 |
| GDF15 and Related Biomarkers | 2021-2025 | 109 | US 28 | 82.00 |
| Intramuscular injections and effects | 2021-2025 | 40 | US 7 | 82.54 |
| Diagnosis and Treatment of Venous Diseases | 2021-2025 | 312 | US 106 | 83.72 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | 2021-2025 | 808 | US 323 | 84.67 |
| Blood properties and coagulation | 2021-2025 | 307 | US 86 | 76.28 |
| Cardiac tumors and thrombi | 2021-2025 | 658 | US 213 | 73.17 |
| Neutropenia and Cancer Infections | 2021-2025 | 787 | US 271 | 70.56 |
| Apelin-related biomedical research | 2021-2025 | 663 | US 104 | 37.65 |
